trial evaluating the safety and efficacy of the company’s Aventus Thrombectomy System for the treatment of pulmonary embolism (PE). A total of 130 patients with intermediate-risk PE were enrolled in ...

ANTICOAGULANT treatment is winning for itself a firm place in the armamentarium against postoperative venous thrombosis and pulmonary embolism. This has been accomplished by the sheer weight of ...

In pulmonary embolism, systemic anticoagulation is the cornerstone treatment. Unless a specific contraindication exists, professional guidelines recommend LMWH and DOACs over UFH for the majority ...

(NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving patient ...

We are honored to be recognized as one of the best hospitals in the country for a third year in a row, says Marcia Manker , ...

Inquis Medical, a leading innovator in venous thromboembolic disease treatment, today announced completion of patient enrollment in its AVENTUS Clinical Trial, ...

The Food and Drug Administration’s approval of Ozempic in 2021 for weight loss treatment ushered in a new era for the class ...

The Janus kinase inhibitor baricitinib, in combination with narrowband ultraviolet B therapy, improved vitiligo, according to a study.“The use of phototherapy alongside [Janus kinase (JAK)] inhibitors ...